1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERICEL CORP
Vericel Corp XNAS: VCEL

Vericel Corp Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondroc...

Read More
35.58 -0.31 (-0.86%)
43.52% Fall from 52W High
231.9K
XNAS Volume

XNAS 28 Aug, 2025 3:34 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Mid Valuation
34.2 / 100
Momentum Score
Technically Neutral
35.1 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
54
1Yr Price target upside is 51%
8 analysts

12

S

11

W

3

O

1

T

SWOT Analysis

Vericel Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..